Prostate cancer: New combination therapy could reduce progression risk

Medical Mythbusting Commentary for March 27, 2023

[display_podcast]

Source:
Prostate cancer: New combination therapy could reduce progression risk

Reference:
TALAPRO-2 Supports First-Line Talazoparib/Enzalutamide in All-Comers With mCRPC